Collateral for a security interest recorded Apr 27, 2026 (Citibank, N.A.).
Term ends Jul 19, 2036 · Medium confidence
20-year base term ends Jul 19, 2036
Why Medium: A parent in the chain could not be resolved.
Held by Amicus Therapeutics, Inc.
Filed Jan 18, 2019 as application 16/318,905 · Granted Aug 27, 2024
Base term, 20 years from filing
Today
2016
2036
Clock starts
Jul 19, 2016
Jul 19, 2016
Term ends
Jul 19, 2036
Jul 19, 2036
Granted
Aug 27, 2024
Aug 27, 2024
base term
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 19, 2016, when the earliest non-provisional application in its chain was filed (this one was filed Jan 18, 2019); a parent in its chain could not be resolved (the next row) | Jul 19, 2036 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 19, 2036 | Medium confidence |
This family
| US 9,056,101 | In force Nov 2030 | Nov 2030 |
| US 9,999,618 | In force Apr 2028 | Apr 2028 |
| US 10,925,866 | In force Apr 2028 | Apr 2028 |
| US 11,033,538 | In force Apr 2028 | Apr 2028 |
| US 10,525,045 | In force Apr 2028 | Apr 2028 |
| US 12,070,453 | this patent Jul 2036 | Jul 2036 |
| US 12,599,595 | In force Apr 2028 | Apr 2028 |
| US 12,599,594 | In force Jul 2036 | Jul 2036 |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 11, 2020 Reel 52625, frame 916 | Amicus Therapeutics, Inc. | Biopharma Credit PLC | Security Interest |
| May 21, 2020 Reel 52741, frame 173 | Biopharma Credit PLC | BPCR Limited Partnership | Omnibus Confirmation of Assignment Agreement |
| Jul 30, 2020 Reel 53360, frame 659 | BPCR Limited Partnership | Amicus Therapeutics, Inc. | Release of Security Interest |
| Jul 30, 2020 Reel 53365, frame 342 | Amicus Therapeutics, Inc. | Hayfin Services LLP, as Agent | Security Interest |
| Oct 6, 2023 Reel 65177, frame 196 | Amicus Therapeutics, Inc. | Wilmington Trust, National Association | Security Interest |
| Oct 6, 2023 Reel 65164, frame 945 | Hayfin Services LLP | Amicus Therapeutics, Inc. | Release of Security Interest |
| Jul 11, 2024 Reel 67959, frame 418 | Castelli, Jeff | Amicus Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 27, 2026 Reel 75493, frame 968 | Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 27, 2026 Reel 75494, frame 30 | Wilmington Trust, National Association | Amicus Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jul 2036
Term ends Jul 19, 2036. Maintenance fees still fall due before then
Citations
50
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.